The Family Firm’s Thermo Fisher Scientific TMO Stock Holding History

The Family Firm’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-27	Closed	-$15K	–	777
2024 Q2	$15K	Buy	+27	New	+$15.5K	﹤0.01%	616

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

The Family Firm's TMO Position: Q3 2024 in Review

The Family Firm sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 27 shares — an estimated $15K sold.

The Family Firm first reported a position in TMO in Q2 2024 and held it in 1 quarter. The position peaked at $15K in Q2 2024. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

The Family Firm reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 27 Thermo Fisher Scientific shares in Q3 2024, an estimated $15K.
The Family Firm first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 1 quarter.
The Family Firm's Thermo Fisher Scientific position peaked at $15K in Q2 2024.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.